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EDITORIAL 
The infectious diseases are commonly caused by disease-causing 
microorganisms and it may lead to the death. The tool for recombinant proteins 
production is achieved by the advent of recombinant DNA technologies and these 
recombinant proteins are used as therapeutic agents to cure the infectious diseases. 
Many expression systems for the pharmaceuticals production have been developed 
through which various types of immunoglobulins, enzymes and edible vaccines are 
synthesized that are used as prophylactic or as therapeutics. Biopharmaceutical and 
edible vaccines derived from the plants have several advantages as it involves 
simple and convenient approach, provide high yield of proteins, have lower storage 
and production cost, the removal of the pathogen contamination, the less processing 
required, as well as the safe delivery of the oral vaccines (Fahad et al., 2015). In 
1989, immunoglobulins derived from transgenic tobacco plant were assembled as 
functional antibodies (Hiatt et al., 1989). Several studies confirmed that plants can be 
used to produce edible vaccines.  
In plants the expression of the biopharmaceutical proteins is based on both the 
stable and transient expression systems. Several problems are associated with 
nuclear transformation including gene silencing (Chebolu and Daniell, 2009), low 
yields, a high risk of the transgene contamination etc. The use of chloroplasts 
transformation for the industrial production of pharmaceutical compounds like 
antibodies, growth factors, cytokines, and antigens, enzymes and hormones is an 
alternative strategy (Daniell et al., 2009; Lössl and Waheed, 2011). Thus, high-
throughput methods that couple gene identification and phenotype observations are 
required to put potential products into the hands of plant breeders to get better 
varieties (Hood and Requesens, 2012; Rech et al., 2014; Sukenik et al., 2018). 
Recent developments including optimization of environmental conditions are crucial 
for efficient recombinant protein production in transient expression systems (Fujiuchi 
et al., 2016).  
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Plants act as an ideal biofactroy for the synthesis of 
antigens which play an important role in development of 
diagnostic test, as well as it is important to produce 
vaccines that are directed against diseases with epidemic 
potential. The expression of vaccine linked protein in 
transgenic form of tobacco plants enhanced the usage of 
plants as biofactories (Hiatt et al., 1989). Plant based 
vaccines can be stored at room temperature for long time 
in dried form. Efficiency of plant based vaccines has also 
shown great importance in animal models. Many reports 
have shown the high immunogenicity of vaccine candidates 
in different models of animals. Many vaccines and 
therapeutic compounds can be obtained from plants by 
many ways in green house, in the field and in cell or root 
cultures. Government should allocate more funds for plant 
based vaccines research and for further commercialization. 
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